MAM
SUPN icon

Meeder Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Meeder Asset Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,774
Closed -$47.5K – 951
2024
Q2 		$47.5K Buy
+1,774
New +$51.4K ﹤0.01% 346
2022
Q4 		– Sell
-17
Closed -$1K – 1862
2022
Q3 		$1K Buy
17
+1
+6% +$33 ﹤0.01% 2021
2022
Q2 		$0 Sell
16
-229
-93% -$6.56K ﹤0.01% 2424
2022
Q1 		$8K Buy
+245
New +$7.51K ﹤0.01% 1646
2021
Q4 		– Sell
-292
Closed -$8K – 2202
2021
Q3 		$8K Buy
292
+33
+13% +$886 ﹤0.01% 1768
2021
Q2 		$8K Sell
259
-1,660
-87% -$50.9K ﹤0.01% 1795
2021
Q1 		$50K Buy
+1,919
New +$53.7K ﹤0.01% 1106
2020
Q4 		– Sell
-4,946
Closed -$102K – 2200
2020
Q3 		$102K Buy
+4,946
New +$112K 0.01% 777
2019
Q2 		– Sell
-819
Closed -$28K – 2136
2019
Q1 		$28K Sell
819
-61
-7% -$2.27K ﹤0.01% 990
2018
Q4 		$30K Buy
880
+736
+511% +$31.6K ﹤0.01% 943
2018
Q3 		$7K Sell
144
-96
-40% -$4.74K ﹤0.01% 1257
2018
Q2 		$14.4K Sell
240
-952
-80% -$49.3K ﹤0.01% 1050
2018
Q1 		$55K Sell
1,192
-1,329
-53% -$55.5K 0.01% 651
2017
Q4 		$100K Buy
2,521
+249
+11% +$9.84K 0.01% 565
2017
Q3 		$91K Sell
2,272
-110
-5% -$4.76K 0.01% 581
2017
Q2 		$103K Buy
2,382
+2,315
+3,455% +$82.4K 0.01% 555
2017
Q1 		$2K Buy
+67
New +$1.79K ﹤0.01% 1405
2016
Q3 		– Sell
-2,307
Closed -$47K – 935
2016
Q2 		$47K Sell
2,307
-23,509
-91% -$417K ﹤0.01% 732
2016
Q1 		$394K Hold
25,816
– – 0.04% 458
2015
Q4 		$347K Sell
25,816
-23,351
-47% -$361K 0.03% 438
2015
Q3 		$690K Buy
+49,167
New +$914K 0.07% 273

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Meeder Asset Management's SUPN Position: Q3 2024 in Review

Meeder Asset Management sold out of Supernus Pharmaceuticals (SUPN) in Q3 2024, closing a stake of 1,774 shares — an estimated $47.5K sold.

Meeder Asset Management first reported a position in SUPN in Q3 2015 and held it in 21 quarters. The position peaked at $690K in Q3 2015. 273 funds tracked by Wall St. Rank hold SUPN as of Q3 2024.

  • Meeder Asset Management reported no remaining Supernus Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Meeder Asset Management sold 1,774 Supernus Pharmaceuticals shares in Q3 2024, an estimated $47.5K.
  • Meeder Asset Management first reported a position in Supernus Pharmaceuticals in Q3 2015 and held it in 21 quarters.
  • Meeder Asset Management's Supernus Pharmaceuticals position peaked at $690K in Q3 2015.
  • 273 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2024.

Based on Meeder Asset Management's 13F filing for Q3 2024, filed 7 Nov 2024.